Dan Marks PhD
Dr. Marks is a Principal on the Venture Team at RA Capital Management. Dr. Marks’ primary responsibility at RA Capital is to identify compelling opportunities to help facilitate new company creation or investments in emerging seed-stage companies. He holds a BS with Honors in Biology from Yale University and a PhD in Cancer Biology from the Gerstner Sloan Kettering School of Biomedical Sciences. Dr. Marks’ graduate research focused on identifying novel targets for disrupting the cell cycle in cancer cells.